New Delhi: Sputnik V will be made by another Indian pharmaceutical firm Virchow Biotech Private Limited, which will be the 5th partnership for making the vaccine in India.
It will manufacture 200 million vaccine doses per year.
The Russian vaccine has an efficacy of 91.6 per cent.
“Vaccine partnerships are the only way to overcome the pandemic. The world continues its fight against coronavirus and we see a growing interest in Sputnik V vaccine as it is one of the most efficient vaccines available. The agreement with Virchow Biotech is an important step to facilitate the full-scale local production of the vaccine in India and to supply our international partners globally,” said chief executive officer of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev.
Sputnik V was the world’s first registered vaccine against COVID-19.
RDIF on Friday had announced its partnership with Stelis Biopharma Pvt Ltd to make 200 million doses here. Dr Reddy’s is already making the vaccine in India. Two other Hyderabad-based players, Hetero and Gland Pharma, will be supplying 100 million and 252 million vaccine doses respectively. The vaccine is likely to be approved in India soon.
New Delhi: The Supreme Court on Friday dismissed a Habeas Corpus petition filed by a…
New Delhi: Surrounded by heavy security, Bollywood actor Salman Khan arrived on the set of…
Bhubaneswar: The regional centre of India Meteorological Department (IMD) has issued nowcast warning for 12…
Jajpur/Koraput: Two separate incidents of theft have turned the light on safety of tourists in…
Bhubaneswar: The Odisha government has reconstituted a task force to suggest measures for implementing the…
New Delhi: Almost 11 months after the US first accused an unnamed Indian official, CC-1,…
Srinagar: In his first cabinet meeting on Thursday, Jammu and Kashmir Chief Minister Omar Abdullah introduced…
Rayagada: A mother-daughter duo lost their limbs after falling off a train at Singapur Road…